García-Villarreal OA

Idioma: Ingles.
Referencias bibliográficas: 5
Paginas: 43-44
Archivo PDF: 464.38 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Alabbadi S, Stebbins A, Vemulapalli S, et al. Trends in case mix andoutcomes after transcatheter aortic valve replacement in patientsyounger than 65 years: insights from the STS/ACC TVT Registry.J Am Coll Cardiol. 2026: S0735-1097(26)00072-0. doi: 10.1016/j.jacc.2026.01.011.

2. FDA expands TAVR indication to low-risk patients [Internet].American College of Cardiology. [cited 2026 Mar 4]. Availablein: https://www.acc.org/Membership/Sections-and-Councils/Interventional-Section/Section-Updates/2019/08/19/08/16/FDAExpands-TAVR-Indication-to-Low-Risk-Patients

3. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valvereplacement with a balloon-expandable valve in low-risk patients. NEngl J Med. 2019;380(18):1695-1705. doi: 10.1056/NEJMoa1814052.

4. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valvereplacement with a self-expanding valve in low-risk patients. N Engl JMed. 2019;380(18):1706-1715. doi: 10.1056/NEJMoa1816885.

5. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHAGuideline for the Management of Patients with valvular heartdisease: executive summary: a report of the American College ofCardiology/American Heart Association Joint Committee on ClinicalPractice Guidelines. Circulation. 2021;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.